Arbutus Biopharma
ABUS
$2.72
Share price
-1.09%
Change (1 day)
-5.88%
Change (1 year)
Categories
Market capitalization of Arbutus Biopharma (ABUS)
Market cap: $0.49 Billion
As of April 2024 Arbutus Biopharma has a market cap of $0.49 Billion. This makes Arbutus Biopharma the world's 5991th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Arbutus Biopharma from 2007 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.49 B | 16.9% |
| 2023 | $0.41 B | 15% |
| 2022 | $0.36 B | -35.88% |
| 2021 | $0.56 B | 88.63% |
| 2020 | $0.30 B | 67.38% |
| 2019 | $0.18 B | -17.77% |
| 2018 | $0.21 B | -21.24% |
| 2017 | $0.27 B | 106.95% |
| 2016 | $0.13 B | -44.67% |
| 2015 | $0.24 B | -28.56% |
| 2014 | $0.33 B | 123.91% |
| 2013 | $0.15 B | 113.97% |
| 2012 | $70.95 M | 289.37% |
| 2011 | $18.22 M | -62.5% |
| 2010 | $48.59 M | 2.16% |
| 2009 | $47.56 M | 223.28% |
| 2008 | $14.71 M | -57.85% |
| 2007 | $34.9 M |
End of Day market cap according to different sources
On Apr 24th, 2024 the market cap of Arbutus Biopharma was reported to be:
$0.49 Billion
$0.49 Billion
$0.49 Billion
$0.49 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $18.25 M | -96.28% | Bahamas |
 NRC Health
NRC | $0.80 B | 63.62% | 🇺🇸 USA |